Week of January 18th 2022 | Vol. 11, Issue 3
|
|
|
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates
Quick Links
Contact Information
Managing Director
Business Development
Managing Director
Head of M&A and Capital Advisory
|
|
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
|
|
Events Hosted or Attended by Bourne Partners
|
|
March 21-24, 2022 - New York City, NY
October 2022- Charlotte, NC
|
|
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
|
|
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
|
|
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
|
|
|
Pharma & Biotech
11 transactions totaling $227 million
Supplies, Equipment & Services
28 transactions totaling $1,320 million
Healthcare IT & Managed Care
13 transactions totaling $50
Healthcare Facilities & Distributors
10 transactions totaling $382 million
|
|
|
Pharma & Biotech
26 transactions totaling $579 million
Supplies, Equipment & Services
17 transactions totaling $298 million
Healthcare IT & Managed Care
22 transactions totaling $918 million
Healthcare Facilities & Distributors
2 transactions
|
|
|
Pharma & Biotech
11 transactions totaling $394 million
Supplies, Equipment & Services
5 transactions totaling $800 million
Healthcare IT & Managed Care
0 transactions
Healthcare Facilities & Distributors
0 transactions
|
|
TRADING COMPS
A Breakdown of Relevant Trading Multiples
|
|
|
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.
For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table.
Note: data reflects prior week close.
|
|
MARKET REPORTS
Insight Into Healthcare Related Industries
|
|
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
|
|
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business
Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America
Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
|
|
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
|
|
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
|
|
Following the death of George Floyd and the many disparities exacerbated by the COVID-19 pandemic, Blue Cross Blue Shield of Massachusetts began asking what role it could play as a health plan.
The two strategies the organization recognized it had access to were data quality and physician payments, said Sandhya Rao, M.D., chief medical officer of BCBS Massachusetts.
“Without great data, it’s really hard to take action and to learn and study the problem,” Rao said during a panel discussion at the virtual J.P. Morgan Healthcare Conference Tuesday.
|
|
December 2021 - Pine Tree Equity
|
Pine Tree Equity IV, LP ("Pine Tree Equity"), a private equity firm based in Miami, FL, is pleased to announce that it has recapitalized Summit Health Pharmacy, LLC ("Summit" or the "Company") in December 2021. The Company, founded in 1995 and headquartered in Brookhaven, PA, is a leading provider of pharmacy compounding services, with a focus on rare pediatric metabolic medications.
|
|
January 10, 2022 - Fierce Healthcare
|
Revenue cycle management company R1 RCM on Monday announced it plans to acquire Cloudmed in an all-stock transaction that values the software company at roughly $4.1 billion. The deal was announced in a press release as the industry meets virtually for the J.P. Morgan Healthcare Conference.
|
|
January 10, 2022- Fierce Healthcare
|
Digital health had another standout year in 2021, with startups raising an eye-popping $29.1 billion across 729 deals, according to Rock Health, a venture fund dedicated to digital health. Overall, investment in the market nearly doubled 2020’s $14.9 billion former record haul, the company noted in its year-end funding report.
|
|
January 11, 2022- Fierce Healthcare
|
After launching from stealth last March, Transcarent has landed $200 million in series C funding to power its premium-free approach to employer-sponsored healthcare. The infusion of capital bumps the company’s valuation to $1.62 billion, boosting Transcarent to the ranks of digital health unicorns, the startup confirmed to Fierce Healthcare.
|
|
The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.
|
|
Check out Tanner’s feature in the 2022 CTS Handbook highlighting the company’s capabilities in solving the most complex sourcing and supply challenges.
|
|
|
|
|
|
|